Polk RE - Search Results

1

Significant Regional Differences in Antibiotic Use Across 576 US Hospitals and 11 701 326 Adult Admissions, 2016-2017.

Goodman KE, Cosgrove SE, Pineles L, Magder LS, Anderson DJ, Dodds Ashley E, Polk RE, Quan H, Trick WE, Woeltje KF, Leekha S, Harris AD. Goodman KE, et al. Among authors: polk re. Clin Infect Dis. 2021 Jul 15;73(2):213-222. doi: 10.1093/cid/ciaa570. Clin Infect Dis. 2021. PMID: 32421195 Free PMC article.

2

Electronically Available Patient Claims Data Improve Models for Comparing Antibiotic Use Across Hospitals: Results From 576 US Facilities.

Goodman KE, Pineles L, Magder LS, Anderson DJ, Ashley ED, Polk RE, Quan H, Trick WE, Woeltje KF, Leekha S, Cosgrove SE, Harris AD. Goodman KE, et al. Among authors: polk re. Clin Infect Dis. 2021 Dec 6;73(11):e4484-e4492. doi: 10.1093/cid/ciaa1127. Clin Infect Dis. 2021. PMID: 32756970 Free PMC article.

3

Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy.

Polk RE, Fox C, Mahoney A, Letcavage J, MacDougall C. Polk RE, et al. Clin Infect Dis. 2007 Mar 1;44(5):664-70. doi: 10.1086/511640. Epub 2007 Jan 22. Clin Infect Dis. 2007. PMID: 17278056

4

Benchmarking risk-adjusted adult antibacterial drug use in 70 US academic medical center hospitals.

Polk RE, Hohmann SF, Medvedev S, Ibrahim O. Polk RE, et al. Clin Infect Dis. 2011 Dec;53(11):1100-10. doi: 10.1093/cid/cir672. Epub 2011 Oct 13. Clin Infect Dis. 2011. PMID: 21998281

5

Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals.

MacDougall C, Powell JP, Johnson CK, Edmond MB, Polk RE. MacDougall C, et al. Among authors: polk re. Clin Infect Dis. 2005 Aug 15;41(4):435-40. doi: 10.1086/432056. Epub 2005 Jun 28. Clin Infect Dis. 2005. PMID: 16028149

6

Predicting hospital rates of fluoroquinolone-resistant Pseudomonas aeruginosa from fluoroquinolone use in US hospitals and their surrounding communities.

Polk RE, Johnson CK, McClish D, Wenzel RP, Edmond MB. Polk RE, et al. Clin Infect Dis. 2004 Aug 15;39(4):497-503. doi: 10.1086/422647. Epub 2004 Aug 2. Clin Infect Dis. 2004. PMID: 15356812

7

Optimal use of modern antibiotics: emerging trends.

Polk R. Polk R. Clin Infect Dis. 1999 Aug;29(2):264-74. doi: 10.1086/520196. Clin Infect Dis. 1999. PMID: 10476723 Review.

8

Effect of ciprofloxacin on the pharmacokinetics and pharmacodynamics of warfarin.

Israel DS, Stotka J, Rock W, Sintek CD, Kamada AK, Klein C, Swaim WR, Pluhar RE, Toscano JP, Lettieri JT, Heller AH, Polk RE. Israel DS, et al. Among authors: polk re. Clin Infect Dis. 1996 Feb;22(2):251-6. doi: 10.1093/clinids/22.2.251. Clin Infect Dis. 1996. PMID: 8838180 Clinical Trial.

9

Benchmarking antimicrobial drug use in hospitals.

Ibrahim OM, Polk RE. Ibrahim OM, et al. Among authors: polk re. Expert Rev Anti Infect Ther. 2012 Apr;10(4):445-57. doi: 10.1586/eri.12.18. Expert Rev Anti Infect Ther. 2012. PMID: 22512754 Review.

10

Effect of clarithromycin on the pharmacokinetics of 2',3'-dideoxyinosine in patients who are seropositive for human immunodeficiency virus.

Gillum JG, Bruzzese VL, Israel DS, Kaplowitz LG, Polk RE. Gillum JG, et al. Among authors: polk re. Clin Infect Dis. 1996 Apr;22(4):716-8. doi: 10.1093/clinids/22.4.716. Clin Infect Dis. 1996. PMID: 8729217 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page